
2 minute read
PULMONARY VASCULAR Disease
Our Comprehensive Pulmonary Vascular Disease Program offers coordinated, multidisciplinary expertise by a team of specialists in cardiology, pulmonary hypertension, vascular medicine, anticoagulation management, hematology, emergency medicine, hospital medicine, interventional cardiology, interventional radiology, and cardiothoracic surgery.
Patients have access to high-quality, progressive care across the entire spectrum of disease, including acute and chronic pulmonary embolism (PE), pulmonary hypertension, specifically chronic thromboembolic pulmonary hypertension (CTEPH), and pulmonary veno-occlusive disease.
PULMONARY ARTERIAL HYPERTENSION (PAH) AND MEDICALLY TREATED PULMONARY HYPERTENSION
• Our Pulmonary Hypertension Program is the largest and most experienced program in the state, and one of the largest in the country.
• U-M Health was pivotal in the clinical trials for PAH that led to the first drug in a decade approved for use in the spring of 2024. We also offer multiple Phase 2 and Phase 3 clinical trials of novel therapies for PAH and pulmonary hypertension associated with interstitial lung disease.
• We are a comprehensive, single resource for the care and treatment of patients who live with PAH.

PULMONARY EMBOLISM (PE) AND CTEPH
• The Frankel CVC is a center of excellence with specific expertise in pulmonary endarterectomy and balloon pulmonary angioplasty (BPA). As the only center in Michigan to offer these procedures, we are a regional referral center for CTEPH.
• To deliver optimally integrated care across health systems, we host monthly virtual care coordination conferences with our statewide referring physician community. Patients who are not eligible for the complex, open-heart endarterectomy procedure are treated with minimally invasive BPA. Our highly trained specialists routinely perform pulmonary angiogram and BPA.
• We staff a dedicated, multidisciplinary, 24-hour oncall pulmonary vascular disease service available to referring physicians. This service is a gateway to our pulmonary embolism response team (PERT) as well as our inpatient and outpatient specialized care teams, providing seamless coordination of medical, interventional, and open surgical management.